In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

Large language models (LLMs) were more likely to suggest inferior treatment options when reviewing hypothetical cases when ...

National registry study finds overall survival improved across the board after the introduction of immune checkpoint ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...